ANNA PREJEAN: Open Payments
NPI 1316294671 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$998 in 48 payments from 9 companies in 2025. Trend: 2023 $655 · 2024 $782 · 2025 $998
Food & beverage: $998
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 26 | $451 |
| GENZYME CORPORATION | 11 | $297 |
| Verona Pharma, Inc. | 3 | $71 |
| Amgen Inc. | 2 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
| Regeneron Healthcare Solutions, Inc. | 1 | $35 |
| Viatris Specialty LLC | 1 | $24 |
| Insmed, Inc. | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $18 |
Products named: DUPIXENT, NUCALA, TRELEGY ELLIPTA, Ohtuvayre, TEZSPIRE, YUPELRI, Arikayce, OFEV.
Industry payments across LA — which companies pay providers there.
